Publikationen

Wedepohl S, Kaup M, Riese SB, Berger M, Dernedde J, Tauber R, Blanchard V.
N-glycan analysis of recombinant L-Selectin reveals sulfated GalNAc and GalNAc-GalNAc motifs..
J Proteome Res. 2010; 9(7):3403-11.
Buscher K, Riese SB, Shakibaei M, Reich C, Dernedde J, Tauber R, Ley K.
The transmembrane domains of L-selectin and CD44 regulate receptor cell surface positioning and leukocyte adhesion under flow.
J Biol Chem 2010; 285(18):13490-7.
Dernedde J, Enders S, Reissig HU, Roskamp M, Schlecht S, Yekta S.
Inhibition of selectin binding by colloidal gold with functionalized shells..
Chem Comm 2009; (8):932-4.
Papp I, Dernedde J, Enders S, Haag R
Modular synthesis of multivalent glycoarchitectures and their unique selectin binding behaviour.
Chem Comm 2008; (44):5851-3.
Dernedde J, Enders S, Reißig H-U, Roskamp M, Schlecht S, Yekta S
Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion.
EU Patentanmeldung 2007;
Enders S, Bernhard G, Zakrzewicz A, Tauber R
Inhibition of L-selectin binding by polyacrylamide-based conjugates under defined flow conditions.
Biochim Biophys Acta 2007 ; 1770(10):1441-9.
Oostingh GJ, Ludwig RJ, Enders S, Grüner S, Harms G, Boehncke WH, Nieswandt B, Tauber R, Schön MP
Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions.
J Invest Dermatol. 2007; 127(1):90-7.
Licha K, Debus N, Emig-Vollmer S, Hofmann B, Hasbach M, Stibenz D, Sydow S, Schirner M, Ebert B, Petzelt D, Bührer C, Semmler W, Tauber R
Optical molecular imaging of lymph nodes using a targeted vascular contrast agent.
J Biomed Opt 2005; 10(4):41205.
Kilian K, Dernedde J, Mueller EC, Bahr I, Tauber R
The interaction of protein kinase C isozymes alpha, iota, and theta with the cytoplasmic domain of L-selectin is modulated by phosphorylation of the receptor.
J Biol Chem 2004; 279(33):34472-80.
Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R
Identification of nucleolin as a new L-selectin ligand.
Biochem J 2001; 360(Pt. 3):531-8.

Arbeitsgruppenleitung

Dr. rer. nat. Jens Dernedde

Charité – Universitätsmedizin Berlin
Institut für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie
Campus Benjamin Franklin
Hindenburgdamm 30
D-12200 Berlin

Fon: +49 (0)30 84 45 46 39
Fax: +49 (0)30 84 45 41 52